Global Info Research
Business Risk & Industry Analysis Reports

Chemical & Material

According to our (Global Info Research) latest study, the global Liquid Roofing market size was valued at US$ 5921 million in 2024 and is forecast to a readjusted size of USD 8615 million by 2031 with a CAGR of 5.6% during review period. In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience. Increasing demand for energy-efficient buildings is driving the liquid roofing market. Asia-Pacific is the fastest-growing market of liquid roofing, in terms of value and volume, with China dominating the market. This report is a detailed and comprehensive analysis for global Liquid Roofing market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided. Key Features: Global Liquid Roofing market size and forecasts, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2020-2031 Global Liquid Roofing market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2020-2031 Global Liquid Roofing market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2020-2031 Global Liquid Roofing market shares of main players, shipments in revenue ($ Million), sales quantity (K MT), and ASP (USD/MT), 2020-2025 The Primary Objectives in This Report Are: To determine the size of the total market opportunity of global and key countries To assess the growth potential for Liquid Roofing To forecast future growth in each product and end-use market To assess competitive factors affecting the marketplace This report profiles key players in the global Liquid Roofing market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BASF, DuPont, Saint-Gobain, 3M, Akzonobel, Sika, Kraton Performance Polymers, Gaf Materials, Johns Manville, Kemper System, etc. This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals. Market Segmentation Liquid Roofing market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets. Market segment by Type PU/Acrylic Hybrids Polyurethane Acrylic Bituminous Silicone Coatings Market segment by Application Residential Buildings Commercial Buildings Public Infrastructure Industrial Facilities Major players covered BASF DuPont Saint-Gobain 3M Akzonobel Sika Kraton Performance Polymers Gaf Materials Johns Manville Kemper System Market segment by region, regional analysis covers North America (United States, Canada, and Mexico) Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe) Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia) South America (Brazil, Argentina, Colombia, and Rest of South America) Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa) The content of the study subjects, includes a total of 15 chapters: Chapter 1, to describe Liquid Roofing product scope, market overview, market estimation caveats and base year. Chapter 2, to profile the top manufacturers of Liquid Roofing, with price, sales quantity, revenue, and global market share of Liquid Roofing from 2020 to 2025. Chapter 3, the Liquid Roofing competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast. Chapter 4, the Liquid Roofing breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031. Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031. Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Liquid Roofing market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031. Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis. Chapter 13, the key raw materials and key suppliers, and industry chain of Liquid Roofing. Chapter 14 and 15, to describe Liquid Roofing sales channel, distributors, customers, research findings and conclusion.

New Technology

The global siRNA Drugs market size is expected to reach $ 16187 million by 2031, rising at a market growth of 28.2% CAGR during the forecast period (2025-2031). Small interfering RNA (siRNA), sometimes known as short interfering RNA or silencing RNA, is a class of double-stranded RNA at first non-coding RNA molecules, typically 20–24 (normally 21) base pairs in length, similar to miRNA, and operating within the RNA interference (RNAi) pathway. siRNA plays a crucial role in gene silencing and regulation of gene expression. siRNA-based therapeutics have gained significant attention in recent years due to their potential to target specific genes involved in diseases such as cancer, genetic disorders, viral infections, and neurodegenerative diseases. The scope of siRNA drug products encompasses various aspects, including their design, development, testing, and regulatory approval. Core manufacturers of siRNA Drugs include Alnylam, Novartis, Novo Nordisk, Genzyme and Arrowhead. USA is the largest consumption region, accounting for approximately 57% of the global market, followed by Europe. In terms of product type, subcutaneous injection are the largest market segment, with a share of more than 77%. In terms of product application, the largest application market is nervous system therapy, with a share of approximately 52%. In-depth analysis of siRNA drug market driving factors I. Technological breakthroughs: the leap from laboratory to clinic Delivery system innovation Lipid nanoparticle (LNP) technology optimization: Early siRNA drugs were limited to the field of rare diseases due to low delivery efficiency and insufficient targeting. In recent years, through technological breakthroughs such as ionized lipid component improvement and PEG modification, LNP can achieve liver-targeted delivery (such as Alnylam's Onpattro) or cross the blood-brain barrier (such as Denali's RVT-1201), significantly broadening the scope of indications. Popularization of GalNAc coupling technology: This technology achieves efficient liver-targeted delivery by binding to asialoglycoprotein receptors, reducing the frequency of administration (such as Novartis' Leqvio subcutaneous injection once every six months), and promoting siRNA to penetrate into chronic diseases such as cardiovascular and metabolic diseases. Mature chemical modification technology Improved stability: Through 2'-O-methyl modification, thiophosphate backbone and other technologies, the half-life of siRNA is extended to several weeks, reducing the risk of immunogenicity. Reduced off-target effects: AI-assisted sequence design (such as Sirnaomics' AI algorithm) combined with bioinformatics screening improves siRNA specificity and significantly improves clinical safety. 2. Market demand: The outbreak of unmet clinical needs Indications expand from rare diseases to common diseases Breakthrough in chronic diseases: Among the approximately 1 billion cardiovascular disease patients worldwide, the market potential for hypercholesterolemia is huge. New paradigm for tumor treatment: siRNA combined with PD-1 inhibitors (such as Arrowhead's ARO-HIF2) shows synergistic effects in the treatment of renal cancer, pushing tumor immunotherapy into the era of gene regulation. The rise of personalized medicine: siRNA therapy based on genotyping (such as Alzheimer's disease drugs for patients with APOE4 mutations) meets the needs of precision treatment and increases patients' willingness to pay. 3. Policy support: Improvement of the global regulatory framework China's policy dividends "The 14th Five-Year Plan for the Development of the Pharmaceutical Industry": Clearly support the development of new delivery systems and nucleic acid drugs, and provide tax incentives and research and development subsidies. Priority review channel: CDE implements fast approval for innovative siRNA drugs, such as Sirnaomics' STP705 (treatment of squamous cell skin cancer) included in the breakthrough therapy. International regulatory coordination FDA accelerated approval: Onpattro (2018) was approved as the first siRNA drug, turning on the regulatory green light. EMA adaptive path: Allows conditional approval based on alternative endpoints (such as biomarker changes) to shorten the R&D cycle. IV. Capital influx: catalytic effect of industrial ecology Increased investment and financing activity Global capital layout: 33 financings in the field of small nucleic acid drugs in 2022, with an amount of nearly US$6 billion (such as Sirnaomics IPO raising US$150 million). MNC giants enter the market: Roche acquires Dicerna for US$2.8 billion, and Novartis and Alnylam reach a US$3.5 billion cooperation to accelerate pipeline development. CDMO service ecosystem matures RiboBio, WuXi AppTec: Provide "one-stop" services from sequence design to cGMP production, reducing R&D costs by more than 50%. Breakthrough in large-scale production: Through continuous flow synthesis technology, the annual production capacity of siRNA has been increased from grams to kilograms, and the cost per dose has been reduced to less than $100. V. Competitive landscape: From technical barriers to ecological barriers Strengthening of patent layout Core patents for delivery systems: Alnylam owns key technology patent clusters such as LNP and GalNAc, forming a technological monopoly. Chemical modification patent network: Ionis' 2'-MOE modification and Sirnaomics' GalNAc-siRNA coupling technology build a patent moat. Cross-border cooperation is accelerating Pharmaceutical company-biotechnology company alliance: For example, AstraZeneca and Silence Therapeutics cooperate to develop cardiovascular siRNA drugs, sharing R&D risks and benefits. Collaborative innovation between industry, academia and research: Harvard University and Moderna cooperate to develop RNA editing technology to promote the transformation of basic research to clinical practice. VI. Challenges and coping strategies Breakthrough in technical bottlenecks Improved tissue penetration: Through cell penetrating peptide (CPP) modification or exosome delivery, the problem of siRNA delivery in organs such as the lungs and brain is solved. Long-term safety assessment: Establish real-time quantitative PCR to monitor off-target effects, and optimize sequence design in combination with single-cell sequencing technology. Balance between cost and accessibility Tiered pricing strategy: Adopt the "patent pool" model (such as MPP) in low-income countries to improve drug accessibility. In the future, siRNA drugs are expected to become the third largest drug type after small molecules and antibodies, reshaping the biopharmaceutical industry landscape. Companies need to focus on core technology breakthroughs, differentiated indication layout and global cooperation to seize market opportunities. This report studies the global siRNA Drugs demand, key companies, and key regions. This report is a detailed and comprehensive analysis of the world market for siRNA Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2024 as the base year. This report explores demand trends and competition, as well as details the characteristics of siRNA Drugs that contribute to its increasing demand across many markets. Highlights and key features of the study Global siRNA Drugs total market, 2020-2031, (USD Million) Global siRNA Drugs total market by region & country, CAGR, 2020-2031, (USD Million) U.S. VS China: siRNA Drugs total market, key domestic companies, and share, (USD Million) Global siRNA Drugs revenue by player, revenue and market share 2020-2025, (USD Million) Global siRNA Drugs total market by Type, CAGR, 2020-2031, (USD Million) Global siRNA Drugs total market by Application, CAGR, 2020-2031, (USD Million) This report profiles major players in the global siRNA Drugs market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Alnylam, Novartis, Novo Nordisk, Genzyme, Arrowhead, Silence, Sylentis, Avidity Biosciences, Sirnaomics, etc. This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals. Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world siRNA Drugs market Detailed Segmentation: Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2020-2031 by year with 2024 as the base year, 2025 as the estimate year, and 2026-2031 as the forecast year. Global siRNA Drugs Market, By Region: United States China Europe Japan South Korea ASEAN India Rest of World Global siRNA Drugs Market, Segmentation by Type Intravenous Injection Subcutaneous Injection Global siRNA Drugs Market, Segmentation by Application: Nervous System Therapy Endocrine and Metabolic Therapy Others Companies Profiled: Alnylam Novartis Novo Nordisk Genzyme Arrowhead Silence Sylentis Avidity Biosciences Sirnaomics Key Questions Answered 1. How big is the global siRNA Drugs market? 2. What is the demand of the global siRNA Drugs market? 3. What is the year over year growth of the global siRNA Drugs market? 4. What is the total value of the global siRNA Drugs market? 5. Who are the Major Players in the global siRNA Drugs market? 6. What are the growth factors driving the market demand?

Agriculture

The global Aquatic Feed market size is expected to reach $ 47841 million by 2031, rising at a market growth of 3.3% CAGR during the forecast period (2025-2031). In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience. Aquatic feed refers to specially formulated feed products designed to meet the nutritional requirements of aquatic animals such as fish, shrimp, crabs, and shellfish raised in aquaculture environments. These feeds are developed based on the species’ dietary needs at different growth stages and are typically composed of proteins, lipids, carbohydrates, vitamins, and minerals. Aquatic feed plays a crucial role in ensuring optimal growth, health, feed efficiency, and product quality in farmed aquatic species. It is manufactured in various physical forms such as pellets, crumbles, powders, and extruded feeds to suit different feeding behaviors and water conditions. Aquatic feed plays a foundational role in the success of modern aquaculture by providing essential nutrition to farmed aquatic species such as fish, shrimp, and shellfish. These feeds are carefully formulated to meet the unique dietary requirements of different species at various life stages, ensuring optimal growth, health, and feed conversion efficiency. Aquatic feeds typically include high-quality proteins, fats, carbohydrates, vitamins, and trace minerals. With global seafood demand on the rise and wild-capture fisheries unable to meet consumption needs, the importance of efficient and sustainable aquatic feed solutions has become more critical than ever. Feed types can vary significantly, from floating or sinking pellets to powdered or extruded formulations, depending on the target species and production system. One of the most important developments in aquatic feed is the shift toward sustainability and innovation. Producers are increasingly adopting alternative protein sources, such as insect meal, algae, or fermented plant ingredients, to reduce reliance on fishmeal and fish oil. Advances in feed technology, including precision formulation and functional additives, help enhance immune function, disease resistance, and water quality management. Additionally, digital tools are being integrated into feeding systems to improve accuracy and reduce waste. Despite progress, challenges such as fluctuating raw material costs, environmental regulations, and disease outbreaks continue to impact the industry. However, with ongoing innovation and investment, aquatic feed will remain a driving force in the future of global aquaculture. This report studies the global Aquatic Feed production, demand, key manufacturers, and key regions. This report is a detailed and comprehensive analysis of the world market for Aquatic Feed and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2024 as the base year. This report explores demand trends and competition, as well as details the characteristics of Aquatic Feed that contribute to its increasing demand across many markets. Highlights and key features of the study Global Aquatic Feed total production and demand, 2020-2031, (Kilotons) Global Aquatic Feed total production value, 2020-2031, (USD Million) Global Aquatic Feed production by region & country, production, value, CAGR, 2020-2031, (USD Million) & (Kilotons), (based on production site) Global Aquatic Feed consumption by region & country, CAGR, 2020-2031 & (Kilotons) U.S. VS China: Aquatic Feed domestic production, consumption, key domestic manufacturers and share Global Aquatic Feed production by manufacturer, production, price, value and market share 2020-2025, (USD Million) & (Kilotons) Global Aquatic Feed production by Type, production, value, CAGR, 2020-2031, (USD Million) & (Kilotons) Global Aquatic Feed production by Application, production, value, CAGR, 2020-2031, (USD Million) & (Kilotons) This report profiles key players in the global Aquatic Feed market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Nutreco, Haid Group, Tongwei Group, BioMar, Cargill, CP Group, Evergreen Feed, New Hope Group, Grobest, Yuehai Feed, etc. This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals. Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Aquatic Feed market Detailed Segmentation: Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Kilotons) and average price (USD/MT) by manufacturer, by Type, and by Application. Data is given for the years 2020-2031 by year with 2024 as the base year, 2025 as the estimate year, and 2026-2031 as the forecast year. Global Aquatic Feed Market, By Region: United States China Europe Japan South Korea ASEAN India Rest of World Global Aquatic Feed Market, Segmentation by Type: Mash Feed Pellet Feed Expanded Feed Other Global Aquatic Feed Market, Segmentation by Application: Fish Feed Shrimp Feed Crab Feed Other Companies Profiled: Nutreco Haid Group Tongwei Group BioMar Cargill CP Group Evergreen Feed New Hope Group Grobest Yuehai Feed Ridley Alpha Feed Dibaq Aquaculture DBN Uni-President Vietnam Aller Aqua GreenFeed Proconco Avanti Feeds Gold Coin Vitapro Tianma Tech Nutriad International Japfa Ltd Alltech Key Questions Answered: 1. How big is the global Aquatic Feed market? 2. What is the demand of the global Aquatic Feed market? 3. What is the year over year growth of the global Aquatic Feed market? 4. What is the production and production value of the global Aquatic Feed market? 5. Who are the key producers in the global Aquatic Feed market? 6. What are the growth factors driving the market demand?

Medical Care

The global Customized Patient Portal market size is expected to reach $ 6417 million by 2031, rising at a market growth of 13.3% CAGR during the forecast period (2025-2031). Customized Patient Portal​​ is a secure, web-based digital platform tailored to meet the specific needs of healthcare providers and their patients. It enables personalized access to medical records, appointment scheduling, communication with care teams, medication management, and other health-related services, enhancing patient engagement and streamlining healthcare delivery. This report studies the global Customized Patient Portal demand, key companies, and key regions. This report is a detailed and comprehensive analysis of the world market for Customized Patient Portal, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2024 as the base year. This report explores demand trends and competition, as well as details the characteristics of Customized Patient Portal that contribute to its increasing demand across many markets. Highlights and key features of the study Global Customized Patient Portal total market, 2020-2031, (USD Million) Global Customized Patient Portal total market by region & country, CAGR, 2020-2031, (USD Million) U.S. VS China: Customized Patient Portal total market, key domestic companies, and share, (USD Million) Global Customized Patient Portal revenue by player, revenue and market share 2020-2025, (USD Million) Global Customized Patient Portal total market by Type, CAGR, 2020-2031, (USD Million) Global Customized Patient Portal total market by Application, CAGR, 2020-2031, (USD Million) This report profiles major players in the global Customized Patient Portal market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Greenway Health, LLC, Athenahealth, Oracle, Epic Systems Corporation, McKesson Corporation, Cerner Corporation, GE Healthcare, NextGen Healthcare Information Systems, Orion Health, Validic, etc. This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals. Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Customized Patient Portal market Detailed Segmentation: Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2020-2031 by year with 2024 as the base year, 2025 as the estimate year, and 2026-2031 as the forecast year. Global Customized Patient Portal Market, By Region: United States China Europe Japan South Korea ASEAN India Rest of World Global Customized Patient Portal Market, Segmentation by Type Web-Based Cloud- Based Global Customized Patient Portal Market, Segmentation by Application: Specialist Hospital Specialist Clinic Companies Profiled: Greenway Health, LLC Athenahealth Oracle Epic Systems Corporation McKesson Corporation Cerner Corporation GE Healthcare NextGen Healthcare Information Systems Orion Health Validic Northwell Health Healow WebMD Health Services Salesforce, Inc. Key Questions Answered 1. How big is the global Customized Patient Portal market? 2. What is the demand of the global Customized Patient Portal market? 3. What is the year over year growth of the global Customized Patient Portal market? 4. What is the total value of the global Customized Patient Portal market? 5. Who are the Major Players in the global Customized Patient Portal market? 6. What are the growth factors driving the market demand?